A
Alpha Clinical Research Georgia | Dunwoody, GA
Research site
(Unclaimed)
Site insights
Top conditions
Top treatments
Osivelotor
Gabapentin
Escitalopram
SAR440340
Desvenlafaxine
Pregabalin
Citalopram
Venlafaxine
Fezolinetant
Dupilumab
Curious how this site stacks up to its peers?
Data sourced from clinicaltrials.gov
Work at this site?
CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.
Active trials
3 of 4 total trials
The purpose of this study is to evaluate the safety, tolerability, efficacy, pharmacokinetics and pharmacodynamics of osivelotor.
Active, not recruiting
Sickle Cell Disease
Drug: Osivelotor
This is an interventional, randomized, parallel group, treatment, Phase 3b/4, double blind, 2-arm study to assess the effect of dupilumab compared to...
Enrolling
Asthma
Drug: Placebo
Drug: Dupilumab
Primary Objective:Evaluate the efficacy of itepekimab compared with placebo on the annualized rate of acute moderate-or-severe COPD exacerbations in...
Active, not recruiting
Chronic Obstructive Pulmonary Disease
Drug: Placebo
Drug: Itepekimab SAR440340
Trial sponsors
Clinical trials
Research sites
Resources
Legal
© Copyright 2025 Veeva Systems